Search Results - "Winklhofer, Franz T"

Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease by Schrier, Robert W, Abebe, Kaleab Z, Perrone, Ronald D, Torres, Vicente E, Braun, William E, Steinman, Theodore I, Winklhofer, Franz T, Brosnahan, Godela, Czarnecki, Peter G, Hogan, Marie C, Miskulin, Dana C, Rahbari-Oskoui, Frederic F, Grantham, Jared J, Harris, Peter C, Flessner, Michael F, Bae, Kyongtae T, Moore, Charity G, Chapman, Arlene B

“…In patients with autosomal dominant polycystic kidney disease, the rate of increase in total kidney volume was not slowed by lisinopril and telmisartan, as…”
Get full text

Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease by Torres, Vicente E, Abebe, Kaleab Z, Chapman, Arlene B, Schrier, Robert W, Braun, William E, Steinman, Theodore I, Winklhofer, Franz T, Brosnahan, Godela, Czarnecki, Peter G, Hogan, Marie C, Miskulin, Dana C, Rahbari-Oskoui, Frederic F, Grantham, Jared J, Harris, Peter C, Flessner, Michael F, Moore, Charity G, Perrone, Ronald D

“…This trial tested single versus dual inhibition of the renin–angiotensin–aldosterone system in ADPKD. ACE-inhibitor monotherapy controlled blood pressure in…”
Get full text

Health-Related Quality of Life in Patients With Autosomal Dominant Polycystic Kidney Disease and CKD Stages 1-4: A Cross-sectional Study by Miskulin, Dana C., MD, Abebe, Kaleab Z., PhD, Chapman, Arlene B., MD, Perrone, Ronald D., MD, Steinman, Theodore I., MD, Torres, Vicente E., MD, Bae, K. Ty, MD, Braun, William, MD, Winklhofer, Franz T., MD, Hogan, Marie C., MD, Rahbari-Oskoui, Fred, MD, Moore, Charity G., PhD, Flessner, Michael F., MD, Schrier, Robert W., MD

“…Background In people with early autosomal dominant polycystic kidney disease (ADPKD), average total kidney volume (TKV) is 3 times normal and increases by an…”
Get full text

Water Prescription in Autosomal Dominant Polycystic Kidney Disease: A Pilot Study by Wang, Connie J, Creed, Catherine, Winklhofer, Franz T, Grantham, Jared J

“…In animal models of polycystic kidney disease, the ingestion of large amounts of water promotes diuresis by suppressing plasma levels of arginine vasopressin…”
Get full text

Analysis of baseline parameters in the HALT polycystic kidney disease trials by Torres, Vicente E, Chapman, Arlene B, Perrone, Ronald D, Bae, K Ty, Abebe, Kaleab Z, Bost, James E, Miskulin, Dana C, Steinman, Theodore I, Braun, William E, Winklhofer, Franz T, Hogan, Marie C, Oskoui, Frederic R, Kelleher, Cass, Masoumi, Amirali, Glockner, James, Halin, Neil J, Martin, Diego R, Remer, Erick, Patel, Nayana, Pedrosa, Ivan, Wetzel, Louis H, Thompson, Paul A, Miller, J Philip, Meyers, Catherine M, Schrier, Robert W

“…HALT PKD consists of two ongoing randomized trials with the largest cohort of systematically studied patients with autosomal dominant polycystic kidney disease…”
Get more information

The HALT Polycystic Kidney Disease Trials: Design and Implementation by Chapman, Arlene B, Torres, Vicente E, Perrone, Ronald D, Steinman, Theodore I, Bae, Kyongtae T, Miller, J Philip, Miskulin, Dana C, Rahbari Oskoui, Frederic, Masoumi, Amirali, Hogan, Marie C, Winklhofer, Franz T, Braun, William, Thompson, Paul A, Meyers, Catherine M, Kelleher, Cass, Schrier, Robert W

“…Two HALT PKD trials will investigate interventions that potentially slow kidney disease progression in hypertensive autosomal dominant polycystic kidney…”
Get full text

Cardiac Magnetic Resonance Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease by Perrone, Ronald D, Abebe, Kaleab Z, Schrier, Robert W, Chapman, Arlene B, Torres, Vicente E, Bost, James, Kaya, Diana, Miskulin, Dana C, Steinman, Theodore I, Braun, William, Winklhofer, Franz T, Hogan, Marie C, Rahbari-Oskoui, Frederic, Kelleher, Cass, Masoumi, Amirali, Glockner, James, Halin, Neil J, Martin, Diego, Remer, Erick, Patel, Nayana, Pedrosa, Ivan, Wetzel, Louis H, Thompson, Paul A, Miller, J Philip, Bae, K Ty, Meyers, Catherine M

“…Autosomal dominant polycystic kidney disease (ADPKD) is associated with a substantial cardiovascular disease burden including early onset hypertension,…”
Get full text

Implications of Donor Disseminated Intravascular Coagulation on Kidney Allograft Recipients by Wang, Connie J, Shafique, Shahzad, McCullagh, Johanna, Diederich, Dennis A, Winklhofer, Franz T, Wetmore, James B

“…Disseminated intravascular coagulation (DIC) is common in deceased kidney donors and is considered a relative contraindication to donation. The significance of…”
Get full text

Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease by Dad, Taimur, Abebe, Kaleab Z., Bae, K. Ty, Comer, Diane, Torres, Vicente E., Czarnecki, Peter G., Schrier, Robert W., Steinman, Theodore I., Moore, Charity G., Chapman, Arlene B., Kaya, Diana, Tao, Cheng, Braun, William E., Winklhofer, Franz T., Brosnahan, Godela, Hogan, Marie C., Miskulin, Dana C., Rahbari Oskoui, Frederic, Flessner, Michael F., Perrone, Ronald D.

“…The high burden of cardiovascular morbidity and mortality in autosomal dominant polycystic kidney disease (ADPKD) is related to development of hypertension and…”
Get full text

Liver Involvement in Early Autosomal-Dominant Polycystic Kidney Disease by Hogan, Marie C, Abebe, Kaleab, Torres, Vicente E, Chapman, Arlene B, Bae, Kyongtae T, Tao, Cheng, Sun, Hongliang, Perrone, Ronald D, Steinman, Theodore I, Braun, William, Winklhofer, Franz T, Miskulin, Dana C, Rahbari-Oskoui, Frederic, Brosnahan, Godela, Masoumi, Amirali, Karpov, Irina O, Spillane, Susan, Flessner, Michael, Moore, Charity G, Schrier, Robert W

“…Background & Aims Polycystic liver disease (PLD), the most common extrarenal manifestation of autosomal-dominant polycystic kidney disease (ADPKD), has become…”
Get full text

Biological Efficacy and Safety of Niacinamide in Patients With ADPKD by El Ters, Mireille, Zhou, Xia, Lepping, Rebecca J., Lu, Pengcheng, Karcher, Rainer T., Mahnken, Jonathan D., Brooks, William M., Winklhofer, Franz T., Li, Xiaogang, Yu, Alan S.L.

“…Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive cyst enlargement, leading to kidney failure. Sirtuin-1 is upregulated in…”
Get full text

ADPKD Progression in Patients With No Apparent Family History and No Mutation Detected by Sanger Sequencing by Braun, William E., Abebe, Kaleab Z., Brosnahan, Godela, Patterson, Charity G., Chapman, Arlene B., Harris, Peter C., Hogan, Marie C., Perrone, Ronald D., Torres, Vicente E., Miskulin, Dana C., Steinman, Theodore I., Winklhofer, Franz T., Rahbari-Oskoui, Frederic F., Czarnecki, Peter G., Bae, Kyongtae T., Grantham, Jared J., Flessner, Michael F., Schrier, Robert W.

Get full text

Improving access to kidney transplantation without decreasing graft survival : Long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipients by BRYAN, Christopher F, WINKLHOFER, Franz T, MURILLO, Daniel, ROSS, Gilbert, NELSON, Paul W, SHIELD, Charles F, WARADY, Bradley A

“…The transplantation of blood group A2/A2B deceased donor kidneys into B recipients could improve access to transplantation for blood group B recipients…”
Get full text

Renal graft survival is not influenced by a positive flow B-cell crossmatch by Bryan, Christopher F, Wakefield, Mark, Reese, Jeffrey C, Shield III, Charles F, Warady, Bradley A, Winklhofer, Franz T, Murillo, Daniel

“…:  Introduction:  The influence of a positive B‐cell crossmatch on graft outcome in renal transplantation is controversial. Methods:  We analyzed graft…”
Get full text

Successful renal transplantation despite low levels of donor-specific HLA class I antibody without IVIg or plasmapheresis by Bryan, Christopher F., McDonald, Scott B., Luger, Alan M., Shield, Charles F., Winklhofer, Franz T., Michael Borkon, A., Warady, Bradley A., Aeder, Mark I., Murillo, Daniel

“…:  We prospectively transplanted 10 primary kidney recipients with deceased donor organs (nine kidney and one pancreas/kidney) when their flow cytometric…”
Get full text

75-P: IVIg reduces the risk of early vascular graft loss in patients with a remote positive HLA class I IgG donor-specific crossmatch by Bryan, Christopher F, Nelson, Paul W, Reese, Jeffrey C, Diederich, Dennis A, Winklhofer, Franz T, Shield, Charles F, Murillo, Daniel, Warady, Bradley A, Wakefield, Mark R

Get full text

Transplantation of A2 and A2B kidneys from deceased donors into B waiting list candidates increases their transplantation rate by Bryan, Christopher F, Nelson, Paul W, Shield, 3rd, Charles F, Ross, Gilbert, Warady, Bradley, Murillo, Daniel, Winklhofer, Franz T

“…Transplant centers in the Midwest Transplant Network began transplanting kidneys from A2 or A2B donors into blood group B and O patients in 1986. Since 1991,…”
Get more information

ABO blood group influences a candidate's likelihood of receiving an HLA zero antigen mismatch kidney by Bryan, Christopher F, Cherikh, Wida S, Cheng, Yulin, Aeder, Mark I, Muruve, Nicolas A, Nelson, Paul W, Shield III, Charles F, Warady, Bradley A, Winklhofer, Franz T

“…:  National sharing of HLA zero‐mismatched kidneys has improved long‐term graft survival. The distribution of those HLA‐matched kidneys by ABO blood group,…”
Get full text

The HALT Polycystic Kidney Disease Trials – Analysis of baseline parameters by Torres, Vicente E., Chapman, Arlene B., Perrone, Ronald D., Bae, K. Ty, Abebe, Kaleab Z., Bost, James E., Miskulin, Dana C., Steinman, Theodore I., Braun, William, Winklhofer, Franz T., Hogan, Marie C., Oskoui, Frederic Rahbari, Kelleher, Cass, Masoumi, Amirali, Glockner, James, Halin, Neil J, Martin, Diego, Remer, Erick, Patel, Nayana, Pedrosa, Ivan, Wetzel, Louis H., Thompson, Paul A., Miller, J. Philip, Meyers, Catherine M., Schrier, Robert W.

“…HALT-PKD consists of two randomized trials comparing treatment with an angiotensin converting inhibitor (ACEI)-angiotensin receptor blocker (ARB) combination…”
Get full text